Interaction kinetics of serum proteins with liposomes and their effect on phospholipase-induced liposomal drug release

Int J Pharm. 2015 Nov 30;495(2):827-39. doi: 10.1016/j.ijpharm.2015.09.053. Epub 2015 Sep 26.

Abstract

We used surface plasmon resonance (SPR) to measure the affinity and kinetics of the interaction between serum proteins and both conventional and PEGylated liposomes. The effect of the interactions on secretory phospholipase A2 (sPLA2)-induced release of a model drug from liposomes was also assessed. SPR analysis of 12 serum proteins revealed that the mode of interaction between serum proteins and liposomes greatly varies depending on the type of protein. For example, albumin bound to liposomes at slower association/dissociation rates with higher affinity and prevented sPLA2-induced drug release from PEGylated liposomes. Conversely, fibronectin bound at faster association/dissociation rates with lower affinity and demonstrated little impact on the drug release. These results indicate that the effect of serum proteins on sPLA2 phospholipid hydrolysis varies with the mode of interaction between proteins and liposomes. Understanding how the proteins interact with liposomes and impact sPLA2 phospholipid hydrolysis should aid the rational design of therapeutic liposomal formulations.

Keywords: Drug release; Liposomes; Phospholipase A2; Serum protein; Surface plasmon resonance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Proteins / metabolism*
  • Drug Liberation*
  • Kinetics
  • Liposomes / chemistry
  • Liposomes / metabolism*
  • Phospholipases A2 / metabolism*
  • Polyethylene Glycols / chemistry
  • Protein Binding*
  • Surface Plasmon Resonance

Substances

  • Blood Proteins
  • Liposomes
  • Polyethylene Glycols
  • Phospholipases A2